Sionna Therapeutics (SION) Earnings Date & Reports

Sionna Therapeutics Inc is a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) patients by developing novel medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator (CFTR) protein to deliver clinically meaningful benefits to CF patients... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

SION is expected to report earnings to fall 21.21% to -51 cents per share on November 11

Sionna Therapeutics SION Stock Earnings Reports

Q3'26

Est.

$-0.52

Q2'26

Missed

by $0.14

Q1'26

Beat

by $0.02

Q4'25

Beat

by $0.25

Q3'25

Beat

by $0.14

The last earnings report on August 06 showed earnings per share of -66 cents, missing the estimate of -51 cents. With 445.77K shares outstanding, the current market capitalization sits at 236.46M.

View a ticker or compare two or three

SION

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

View AI-Driven Trading for SION